ImmunityBio, Inc. · 14 hours ago
Principal Specialist, Global Labeling Regulatory
ImmunityBio, Inc. is a commercial-stage biotechnology company focused on developing innovative cell and immunotherapy products. The Principal Specialist, Global Labeling Regulatory is responsible for the strategic global development, maintenance, and compliance of product labeling throughout a drug's lifecycle, ensuring compliance with regulatory requirements and interacting with cross-functional teams.
Health CareHealth DiagnosticsTherapeutics
Responsibilities
Create and execute global labeling strategies from early clinical development through commercialization
Contribute to writing and maintaining key labeling documents, such as the Company Core Data Sheet (CCDS), US Prescribing Information (USPI), and the EU Summary of Product Characteristics (SmPC)
Ensure that all labeling content and artwork comply with international and local Health Authority regulations (e.g., FDA, EMA, MHRA etc.) and Good Manufacturing Practices (GMP); This includes monitoring for regulatory changes and implementing updates
Act as the primary labeling representative on various project teams, coordinating with departments like Clinical, Safety, Medical Affairs, Quality, Commercial, and Supply Chain
Manage the process of updating label content and artwork for packaging and supplies, coordinating with manufacturing and third-party vendors
Advise internal stakeholders on labeling content, processes, timelines, and potential risks, and present labeling strategies to senior leadership
Lead or support negotiations with Regulatory Agencies regarding the content of product labels
Assist with preparation and review Module 2 (QOS) and Module 3 documents in accordance with eCTD guidance and company standards
Contribute to the development of global CMC regulatory strategies
Assist with the preparation or review of documents including pharmacy manuals, protocols, CMC reports, and other documentation
Assist with the preparation of responses to Health Authority comments and questions pertaining to labeling issues
Develop and adhere to Standard Operating Procedures (SOPs) and process improvements as needed
Performs ad-hoc and cross-functional duties and/or projects as assigned to support business needs and provide developmental opportunities
Qualification
Required
Bachelor's degree with 10+ years' experience working on clinical and commercial labels for varied types of drug products in a global setting required; or
Master's degree with 8+ years of experience working on clinical and commercial labels for varied types of drug products in a global setting required
Experience in Global Health Authority Regulatory labeling requirements for both clinical and commercial stage products required
Expert knowledge in Global Health Authority Regulatory labeling requirements for both clinical and commercial stage products
Proficient in Electronic Document Management Systems
Ability to work with firm deadlines and adapt quickly to changing requirements and priorities
Strong organizational skills, written and oral communication skills, and attention to detail
Keen awareness of cultural sensitivities
Excellent interpersonal skills
Preferred
Experience in the preparation and submission of CMC modules in eCTD format preferred
Familiar with organizing responses to Health Authority requests preferred
Experience in international import and export permits a plus
Benefits
Medical, Dental and Vision Plan Options
Health and Financial Wellness Programs
Employer Assistance Program (EAP)
Company Paid and Voluntary Life/AD&D, Short-Term and Long-Term Disability
Healthcare and Dependent Care Flexible Spending Accounts
401(k) Retirement Plan with Company Match
529 Education Savings Program
Voluntary Legal Services, Identity Theft Protection, Pet Insurance and Employee Discounts, Rewards and Perks
Paid Time Off (PTO) includes: 11 Holidays
Exempt Employees are eligible for Unlimited PTO
Non-Exempt Employees are eligible for 10 Vacation Days, 56 Hours of Health Pay, 2 Personal Days and 1 Cultural Day
Company
ImmunityBio, Inc.
ImmunityBio, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$1.36BKey Investors
Oberland CapitalNantCapitalPatrick Soon-Shiong
2025-07-25Post Ipo Equity· $80M
2025-04-08Post Ipo Equity· $75M
2024-12-11Post Ipo Equity· $100M
Recent News
Los Angeles Business Journal
2025-12-24
Company data provided by crunchbase